BioSpace News Archive

Pulnovo Medical will be attending JPM Healthcare Conference 2023

Pulnovo Medical Limited, a globally recognized OTM innovative platform, will be attending the upcoming 41st J.P. Morgan Healthcare Conference 2023 to discuss the latest trends in innovative technologies and development strategies in the medical device sector with global peers.

December 24, 2022
·
1 min read
Policy

Coherus and Junshi Biosciences Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Shanghai Junshi Biosciences Co., Ltd and Coherus BioSciences, Inc. announced that the companies have not received an action letter from the U.S. Food and Drug Administration regarding the Biologics License Application for toripalimab in combination with chemotherapy as treatment for recurrent or metastatic nasopharyngeal carcinoma by the Prescription Drug User Fee Action date of December 23, 2022.

December 24, 2022
·
8 min read